Depressed Jane

Though effective treatments are available for individuals suffering from chronic depression and anxiety, very little is known about how often these treatments are used or how prevalent these conditions are among the nation’s general population.

Popularity: unranked [?]

Romantic relationships establish special bonds between partners. Oftentimes, passionate rapport leads to permanent partnerships, and ultimately, the start of families. Sometimes, however, one or both partners place too much emotional weight on their relationship. As a result, men or women may tend to evaluate their self-worth solely based on the outcomes of their romantic interactions.

Popularity: unranked [?]

A new universal test to predict the risk of someone succumbing to major depression has been developed by UCL (University College London) researchers. The online tool, predictD, could eventually be used by family doctors and local clinics to identify those at risk of depression for whom prevention might be most useful.

Popularity: 1% [?]

Consumers are burying their heads in the sand when it comes to Christmas spending during the credit crunch, a top psychologist is cautioning. Salford University’s Dr Tom Fawcett associates the psychological phenomenon of ‘cognitive dissonance’ – or conflicting thoughts – for the public’s desire to spend this Christmas – even though they know they can’t afford it.

Popularity: 1% [?]

Research revealed today outlines the success of group-taught meditation therapies, such as mindfulness-based cognitive therapy (MBCT) when treating depression. The Dove Clinic for Integrated Medicine offers a course of MBCT sessions that aim to teach patients the skills needed to help recognise and cope with the signs of depression.

Popularity: 1% [?]

Research shows for the first time that a group-based psychological treatment, Mindfulness Based Cognitive Therapy (MBCT), could be a viable alternative to prescription drugs for people suffering from long-term depression. In a study, published yesterday (1 December 2008) in the Journal of Consulting and Clinical Psychology, MBCT proved as effective as maintenance anti-depressants in preventing a relapse and more effective in enhancing peoples’ quality of life.

Popularity: unranked [?]

IMPAX Laboratories, Inc. announced that the U.S. Food and Drug Administration (FDA) granted final approval of the Company’s Abbreviated New Drug Application (ANDA) for a generic version of Wellbutrin® XL 150 mg Extended-release Tablets on Wednesday, November 26, 2008. GlaxoSmithKline markets Wellbutrin® XL for the management of depression. IMPAX’s Global Pharmaceuticals division launched the product immediately following approval.

Popularity: unranked [?]